Population
Patients with symptomatic ventricular arrhythmias
Design
Review
Authors
Loading...
Limits tocainide to symptom relief only; leaves open any mortality benefit in ventricular arrhythmias.
Tocainide is an oral antiarrhythmic agent introduced for symptomatic ventricular arrhythmias, though no data suggest it prevents sudden cardiac death.
Roden et al. (1986) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: